Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
EV to Sales History
Valuation returning toward historical norms
Left:
||||
Enterprise value to sales ratio
Latest
6.49
↓ 13% below average
Average (9y)
7.47
Historical baseline
Range
High:12.20
Low:4.69
CAGR
+1.8%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | 6.49 | +7.6% |
| 2024 | 6.03 | +28.7% |
| 2023 | 4.69 | -61.6% |
| 2022 | 12.20 | +8.1% |
| 2021 | 11.29 | +65.5% |
| 2020 | 6.82 | +24.3% |
| 2019 | 5.49 | -32.3% |
| 2018 | 8.10 | +0.7% |
| 2017 | 8.04 | +45.6% |
| 2016 | 5.52 | - |